cortisol
发表于 2025-3-26 23:31:04
http://reply.papertrans.cn/23/2212/221126/221126_31.png
AGGER
发表于 2025-3-27 04:02:18
http://reply.papertrans.cn/23/2212/221126/221126_32.png
glomeruli
发表于 2025-3-27 06:08:11
http://reply.papertrans.cn/23/2212/221126/221126_33.png
WAIL
发表于 2025-3-27 11:46:49
Joachim H.R. Lübke,Astrid Rollenhagennition, and (3) it is able to suppress immune reactivity. For colorectal cancer (CRC), there are many evidences connecting tumorigenesis and inflammation, such as the decreased incidence of tumors in individuals under nonsteroidal anti-inflammatory drug treatment. The increased incidence of tumors i
上涨
发表于 2025-3-27 15:14:49
Cell Labeling and FIB–SEM Imagingtage of the cancer, and only a small population is potentially curative by surgical resection. Although gemcitabine-based chemotherapy is typically offered as standard of care, most patients do not survive longer than 6 months. FOLFIRINOX has shown superiority over gemcitabine monotherapy in metasta
Type-1-Diabetes
发表于 2025-3-27 19:20:05
Martin Middeke,Heinrich Holzgreve drugs are not well understood. Macrophages, regulatory T cells, dendritic cells, and pro-inflammatory cytokines modify the colon and pancreatic tumor microenvironments and contribute to tolerance to tumor-associated antigens and immune escape. The initiation and aggressive progression of disease in
Confidential
发表于 2025-3-28 00:10:11
http://reply.papertrans.cn/23/2212/221126/221126_37.png
使绝缘
发表于 2025-3-28 04:02:53
Joseph A. Ball,Israel Gohberg,Leiba Rodmance has been induced by cytotoxic T lymphocytes (CTLs), specific immune suppression is associated with tumor malignancy and progression. This contributes to unsatisfactory clinical outcome. In squamous cell carcinoma of the head and neck, the presence, activity, and also suppression of tumor-specific
certitude
发表于 2025-3-28 07:46:39
http://reply.papertrans.cn/23/2212/221126/221126_39.png
rheumatology
发表于 2025-3-28 11:33:36
https://doi.org/10.1007/3-540-45731-3 of the first forms of immunotherapy for the treatment of sarcoma. With advancements in molecular oncology and the identification of specific sarcoma antigens, direct experimentation has been made possible in a variety of preclinical animal models. Discoveries from the laboratory have led to novel i